A

Abliva AB

16 employees

Abliva develops medicines for the treatment of primary mitochondrial diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Clinical Trials
Biotechnology
Leigh
MELAS
Mitochondrial medicine
primary mitochondrial diseases
Health Care
Mitochondrial disorders

Date founded

2000

Investments made

I

Isomerase Therapeutics Ltd. raised undisclosed on August 15, 2016

Investors: Abliva AB

Funding rounds raised

Total raised

$4.1M

from 4 investors over 4 rounds

A

Abliva AB raised $2M on April 22, 2020

Investors: Hadean Ventures

A

Abliva AB raised $3M on March 7, 2019

Investors: Nyenburgh Investment Partners (NYIP)

A

Abliva AB raised $4.1M on August 29, 2018

Investors: united-states-department-of-defense

A

Abliva AB raised $115K on June 7, 2017

Investors: VINNOVA

FAQ